Event Type: Earnings Conference Call for quarterly and half-yearly results discussion
Event Date: October 26, 2026 (held today as of the disclosure date)
Regulatory Basis: Disclosure made pursuant to Regulation 30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Previous Communications: References previous intimations dated October 12, 2026 ("Intimation of Earnings Conference Call for Q2 & H1 FY27") and October 22, 2026 ("Rescheduling of Earnings Conference Call for Q2 & H1 FY27")
Recording Availability: Audio recording of the earnings conference call is available at: https://www.mankindpharma.com/wp-content/uploads/2026/10/10047665.mp3
Management Participants: Not specified in this disclosure
Financial Period Discussed: Q2 FY27 (Quarter 2) and H1 FY27 (Half Year) results
UPSI Statement: The disclosure does not indicate whether unpublished price sensitive information was shared during the call
Additional Notes Section
Attachments: No attachments mentioned in this specific disclosure
Financial Data Disclosure: This announcement contains no financial data or performance figures - it solely provides access to the earnings call recording
Compliance Officer: Hitesh Kumar Jain, Company Secretary & Compliance Officer, digitally signed the disclosure on October 26, 2026 at 19:35:42 IST
